LGND (LGND) director receives RSUs, stock options and tax-withholding share disposition
Rhea-AI Filing Summary
LIGAND PHARMACEUTICALS INC director Martine Zimmermann reported routine equity compensation and related tax withholding. She received 836 restricted stock units, each convertible into one share of common stock, granted by the board on June 5, 2026. These RSUs fully vest on the earlier of the next annual stockholder meeting or the first anniversary of the grant date. The company also granted her non-qualified stock options for 2,938 shares at an exercise price of $237.00 per share, with the same vesting schedule and expiration in 2036. To cover taxes on RSU settlement, 182 shares of common stock were withheld, a non-market disposition. After these transactions, she directly holds 5,097 common shares and 2,938 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 654 shares
Net Buy
3 txns
Insider
Zimmermann Martine
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) | 2,938 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 836 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 182 | $237.00 | $43K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 2,938 shares (Direct);
Common Stock — 5,097 shares (Direct)
Footnotes (3)
- F1. Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- F2. Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
- F3. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
Key Figures
RSU grant: 836 units
Option grant size: 2,938 options
Option exercise price: $237.00 per share
+4 more
7 metrics
RSU grant
836 units
Common stock RSUs granted June 5, 2026
Option grant size
2,938 options
Non-qualified stock options granted June 5, 2026
Option exercise price
$237.00 per share
Strike price for non-qualified stock options
Tax-withheld shares
182 shares
Shares withheld to cover RSU tax liability
Common shares after transactions
5,279 shares
Direct LGND common stock holdings post-Form 4
Options after transactions
2,938 options
Direct non-qualified stock option holdings post-Form 4
Option expiration
June 5, 2036
Non-qualified stock option term end date
Key Terms
restricted stock units ("RSUs"), Non-Qualified Stock Option (right to buy), tax liability, grant, award, or other acquisition, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Non-Qualified Stock Option (right to buy) financial
"security_title": "Non-Qualified Stock Option (right to buy)""
tax liability financial
"shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement"
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Payment of exercise price or tax liability by delivering securities financial
"transaction_code_description": "Payment of exercise price or tax liability by delivering securities""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Martine Zimmermann receive from LGND on June 5, 2026?
Martine Zimmermann received 836 restricted stock units and non-qualified stock options for 2,938 shares at $237.00 per share. Both grants were approved by the board on June 5, 2026, as part of her director compensation package.
How and when do Martine Zimmermann’s new LGND RSUs and options vest?
Both the 836 RSUs and the 2,938 stock options vest fully on the earlier of the next annual stockholder meeting or the first anniversary of the June 5, 2026 grant date. This creates a single vesting event tied to board and calendar timing.
What is the exercise price and term of Martine Zimmermann’s new LGND stock options?
The non-qualified stock options cover 2,938 shares of LGND common stock at an exercise price of $237.00 per share. They were granted on June 5, 2026 and are scheduled to expire on June 5, 2036, giving a 10-year exercise window after vesting.